Lupus :: Preclinical study suggests organ-transplant drug may aid in lupus fight

A compound related to a drug used in humans to prevent organ-transplant rejection attacks a key biochemical process in the faulty immune cells of lupus-prone mice, suggesting a possible new approach to combating the disease, UT Southwestern Medical Center researchers have found.

Myasthenia Gravis :: New treatment boosts muscle function in myasthenia gravis

A new type of treatment significantly reduces the severity of muscle weakness in myasthenia gravis (MG), giving hope for a new class of drugs to treat neurological disorders, according to a study published in the August 14, 2007, issue of Neurology?, the medical journal of the American Academy of Neurology.